Sienna Cancer Diagnostics announced the appointment of Triolab AB as its exclusive distributor in Sweden. The distribution agreement grants Triolab AB the right to sell Sienna's hTERT product to Swedish pathology laboratories where it can be used as an adjunct in urine cytology assisting pathologists in their diagnosis of bladder cancer, of which there are approximately 2,400 new cases diagnosed annually.